These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2658349)

  • 1. The biology and natural history of breast cancer from the screening perspective.
    Holmberg L; Pontén J; Adami HO
    World J Surg; 1989; 13(1):25-30. PubMed ID: 2658349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial.
    Tabar L; Fagerberg G; Chen HH; Duffy SW; Smart CR; Gad A; Smith RA
    Cancer; 1995 May; 75(10):2507-17. PubMed ID: 7736395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of breast carcinoma: what have we learned from screening?
    Tabár L; Duffy SW; Vitak B; Chen HH; Prevost TC
    Cancer; 1999 Aug; 86(3):449-62. PubMed ID: 10430253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old.
    Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD
    AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
    de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
    J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival.
    Porter GJ; Evans AJ; Cornford EJ; Burrell HC; James JJ; Lee AH; Chakrabarti J
    AJR Am J Roentgenol; 2007 Mar; 188(3):676-83. PubMed ID: 17312053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting which invasive cancers at mammographic screening saves lives?
    Evans AJ; Pinder SE; Burrell HC; Ellis IO; Wilson AR
    J Med Screen; 2001; 8(2):86-90. PubMed ID: 11480449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gauging the impact of breast carcinoma screening in terms of tumor size and death rate.
    Michaelson JS; Satija S; Kopans D; Moore R; Silverstein M; Comegno A; Hughes K; Taghian A; Powell S; Smith B
    Cancer; 2003 Nov; 98(10):2114-24. PubMed ID: 14601080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Hendrick RE
    Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of invasive breast cancers detected by screening mammography.
    Zahl PH; Maehlen J; Welch HG
    Arch Intern Med; 2008 Nov; 168(21):2311-6. PubMed ID: 19029493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).
    Anderson WF; Jatoi I; Devesa SS
    Breast Cancer Res Treat; 2006 Oct; 99(3):333-40. PubMed ID: 16703451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of mammographic screening on the size and the relative frequency of invasion in breast cancers seen in a community hospital from 1975-1988.
    Bennington JL; Lagios MD; Margolin FR
    Pathology (Phila); 1992; 1(1):11-21. PubMed ID: 9420912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of the Swedish two-county program of mammographic screening for breast cancer.
    Tabàr L; Fagerberg G; Duffy SW; Day NE; Gad A; Gröntoft O
    Radiol Clin North Am; 1992 Jan; 30(1):187-210. PubMed ID: 1732926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammographic screening for breast cancer. What cancers do we find?
    Nordén T; Thurfjell E; Hasselgren M; Lindgren A; Norgren A; Bergström R; Holmberg L
    Eur J Cancer; 1997 Apr; 33(4):624-8. PubMed ID: 9274445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benefits and limitations of mass screening. The natural history of breast cancer].
    Tubiana M
    Bull Acad Natl Med; 1998; 182(8):1593-610; discussion 1610-1. PubMed ID: 10188306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
    Welch HG; Prorok PC; O'Malley AJ; Kramer BS
    N Engl J Med; 2016 Oct; 375(15):1438-1447. PubMed ID: 27732805
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.